Skip to main content
. 2022 May 17;80:104062. doi: 10.1016/j.ebiom.2022.104062

Figure 3.

Fig 3

CD40.CoV2 and mRNA BNT162b2 vaccines elicit similar cross-reactive and neutralizing antibody responses. Levels of IgG antibodies (AU) binding to Wuhan and VOCs SARS-CoV-2 RBD proteins (α, β, γ, δ Omicron) (a) and neutralizing activity of anti-RBD antibodies (percentage of inhibition relative to the Wuhan RBD protein) (b) one week after completion of the vaccination schedule in BNT162b2 mRNA (red) or CD40.CoV2 vaccinated animals (blue) (n = 5 and 20 animals, respectively). Medians ± Interquartile ranges (IQRs) are shown.